Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 3 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Sederma maintains a robust presence in the Biotechnology & Pharmaceuticals technology area with 7 pending office actions. These actions are distributed among 7 distinct examiners, which is a high level of examiner diversity for a portfolio of this size. This suggests that Sederma's applications are being reviewed by a wide variety of individuals, each potentially bringing a different perspective to the prosecution process.
The 7 pending office actions are spread across 3 distinct art units. This indicates that while there are many examiners involved, they are concentrated within a few specific departments. The busiest examiner, KELLY-O'NEILL, YOLANDA LYNNETTE, is responsible for only 1 busiest examiner pending office action. This means the workload is perfectly distributed, with each of the 7 distinct examiners handling exactly one pending action. For a practitioner, this represents a highly decentralized prosecution environment. One must manage 7 different examiner relationships across 3 distinct art units, requiring a broad and flexible legal strategy to address the various examination styles present.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (14%) |
| §103 only | 3 (43%) |
| §102 only | 1 (14%) |
| Multi-statute (no §101) | 2 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KELLY-O'NEILL, YOLANDA LYNNETTE | 1 | 33.3% | +29.9% |
| HIBBERT, CATHERINE S | 1 | 58.9% | +48.8% |
| KONOPELSKI SNAVEL, SARA ELIZABETH | 1 | 33.3% | +38.9% |
| KOMATSU, LI N | 1 | 59.8% | +71.1% |
| REYNOLDS, FRED H | 1 | 33.0% | +39.2% |
| JOHNSON, CHRISTOPHER LINDSAY | 1 | 46.9% | +81.0% |
| LEE, JIA-HAI | 1 | 49.0% | +47.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16963578 | USE OF CYCLIC PEPTIDES IN COSMETIC | LEE, JIA-HAI | 42d overdue |
| 18287257 | COMPOSITIONS FOR CHEMICAL SYNTHESIS OF PEPTIDES | KELLY-O'NEILL, YOLANDA LYNNETTE | — |
| 18035840 | TETRAPEPTIDES, COMPOSITIONS COMPRISING THEM, AND THEIR COSMETIC USE | KONOPELSKI SNAVEL, SARA ELIZABETH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17765707 | PEPTIDE BASED COSMETIC OR DERMATOLOGICAL TREATMENT OF THE SKIN AND ITS APPENDAGES | REYNOLDS, FRED H | 44d overdue |
| 16963578 | USE OF CYCLIC PEPTIDES IN COSMETIC | LEE, JIA-HAI | 42d overdue |
| 18018412 | COSMETIC OR DERMATOLOGICAL PEPTIDE-BASED TREATMENT OF THE SKIN AND ITS INTEGUMENTS | KOMATSU, LI N | 2d overdue |
| 18035860 | TETRAPEPTIDES, COMPOSITIONS COMPRISING THEM, AND THEIR COSMETIC USE | HIBBERT, CATHERINE S | 26d |
| 18287257 | COMPOSITIONS FOR CHEMICAL SYNTHESIS OF PEPTIDES | KELLY-O'NEILL, YOLANDA LYNNETTE | — |
| 18035840 | TETRAPEPTIDES, COMPOSITIONS COMPRISING THEM, AND THEIR COSMETIC USE | KONOPELSKI SNAVEL, SARA ELIZABETH | — |
| 17642581 | N-ACYL-TYROSINE DERIVATIVES AND USES THEREOF | JOHNSON, CHRISTOPHER LINDSAY | — |
| Art Unit | Apps |
|---|---|
| 1658 | 5 |
| 1692 | 1 |
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18287257 | COMPOSITIONS FOR CHEMICAL SYNTHESIS OF PEPTIDES | KELLY-O'NEILL, YOLANDA LYNNETTE | 1692 | §102§112 | Non-Final OA | — | Pending | Oct 17, 2023 |
| 18035860 | TETRAPEPTIDES, COMPOSITIONS COMPRISING THEM, AND THEIR COSMETIC USE | HIBBERT, CATHERINE S | 1658 | §103 | Non-Final OA | 26d | Pending | May 08, 2023 |
| 18035840 | TETRAPEPTIDES, COMPOSITIONS COMPRISING THEM, AND THEIR COSMETIC USE | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | §102§112 | Final Rejection | — | Pending | May 08, 2023 |
| 18018412 | COSMETIC OR DERMATOLOGICAL PEPTIDE-BASED TREATMENT OF THE SKIN AND ITS INTEGUMENTS | KOMATSU, LI N | 1658 | §103 | Final Rejection | 2d overdue | Pending | Jan 27, 2023 |
| 17765707 | PEPTIDE BASED COSMETIC OR DERMATOLOGICAL TREATMENT OF THE SKIN AND ITS APPENDAGES | REYNOLDS, FRED H | 1658 | §102Other | Non-Final OA | 44d overdue | Pending | Mar 31, 2022 |
| 17642581 | N-ACYL-TYROSINE DERIVATIVES AND USES THEREOF | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §103 | Final Rejection | — | Pending | Mar 11, 2022 |
| 16963578 | USE OF CYCLIC PEPTIDES IN COSMETIC | LEE, JIA-HAI | 1658 | §101§103§112 | Final Rejection | 42d overdue | Pending | Jul 21, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial